Results 31 to 40 of about 55 (55)
Some of the next articles are maybe not open access.
Valores de referencia de la actividad enzimática alfa-glucosidasa ácida linfocitaria
Revista del Laboratorio Clínico, 2016Resumen Introduccion La enfermedad de Pompe, tambien denominada deficit de maltasa acida o glucogenosis tipo ii, es un trastorno metabolico autosomico recesivo caracterizado por un acumulo anormal de glucogeno lisosomal, causado por la deficiencia de la enzima α-glucosidasa acida (GAA). Segun la edad de inicio y el grado de afectacion organica, la
Borja del Castillo Figueruelo +3 more
openaire +1 more source
Revista de Neurología, 2013
INTRODUCTION. Glycogen storage disease type II, or Pompe disease, is a lysosomal disease with an autosomal recessive pattern of inheritance. Late-onset Pompe disease is a progressive metabolic myopathy caused by decreased activity of the enzyme acid alpha-glucosidase (GAA), which gives rise to reduced degradation and later accumulation of glycogen in ...
José Guevara Campos +3 more
openaire +1 more source
INTRODUCTION. Glycogen storage disease type II, or Pompe disease, is a lysosomal disease with an autosomal recessive pattern of inheritance. Late-onset Pompe disease is a progressive metabolic myopathy caused by decreased activity of the enzyme acid alpha-glucosidase (GAA), which gives rise to reduced degradation and later accumulation of glycogen in ...
José Guevara Campos +3 more
openaire +1 more source
Estigmas de maices autóctonos Mexicanos y su capacidad para inhibir alfa-glucosidasas intestinales.
2017Alvarado-Díaz, Samara +1 more
openaire +1 more source
Impact of Alfa fibers morphology on hydration kinetics and mechanical properties of cement mortars
Construction and Building Materials, 2021Jonathan Page +2 more
exaly
Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C
Advanced Drug Delivery Reviews, 2002Rajender Reddy
exaly